Cardium Provides Update On Commercial Development Plans For Generx Angiogenic Therapy For Heart Disease At 2010 Cell & Gene Therapy Forum

Links shared publicly online about this topic.

  • 1,426
    total visits

Cardium Provides Update On Commercial Development Plans For Generx Angiogenic Therapy For Heart Disease At 2010 Cell & Gene Therapy Forum

medicalnewstoday.com —

Cardium therapeutics (nyse amex: cxm) reported that its cardium biologics division provided an update on plans for the continuing commercial development of generx™ (alferminogene tadenovec,

View full resource at medicalnewstoday.com

Tags: Heart, Heart Disease, Coronary Artery Disease, Disease and Condition, Forum, Genes

  • Share

Most Recently Shared on January 27, 2010 at 5:18 pm By:

mnt_heart MNT Heart News

Cardium Provides Update On Commercial Development Plans For Generx Angiogenic Therapy For Heart Disease At 2010 Cell ... http://mnt.to/3wPn

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Genetics News MNT Genetics News

MNT Cardiovascular MNT Cardiovascular

MNT Clinical Trials MNT Clinical Trials

Advertisement